$66.51
1.061.62%
最終更新: Nov 11, 4:00 PM
Benzinga
Benzinga
Benzinga
木曜日, 11 12
Benzinga
© 2026 Benzinga | All Rights Reserved
Eastman Chemical rose 9.1% from $60.94 to $66.51, behind the S&P 500's +11.2%. Its worst day was Jun 29 (−5.4%), and its low came Nov 20 at $56.37.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Eastman Chemical closed at its lowest level of the year, 7.5% below where the year started.
−1.9% · S&P 500 −1.5%
Eastman Chemical shares rose 6.1%, while the S&P 500 rose 0.7%.
+6.1% · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
Eastman Chemical shares rose 5.5%, while the S&P 500 rose 0.6%.
+5.5% · S&P 500 +0.6%
EPS of $0.75 beat the $0.74 estimate on $2.0B revenue (est. $2.0B); Q1 EPS guidance of $1.00–$1.20 against the $0.74 consensus.
+0.5% · S&P 500 −0.3%
Eastman Chemical closed at its highest level of the year, 33.5% above where the year started.
+1.0% · S&P 500 0.0%
Eastman Chemical shares rose 5.2%, while the S&P 500 rose 2.9%.
+5.2% · S&P 500 +2.9%
EPS of $1.09 beat the $1.07 estimate on $2.2B revenue (est. $2.2B); Q2 EPS guidance of $1.70–$1.90 against the $1.67 consensus.
+6.1% · S&P 500 +0.3%
Eastman Chemical shares fell 5.4%, while the S&P 500 rose 1.6%.
−5.4%, the year's worst day · S&P 500 +1.6%
EPS of $1.97 beat the $1.81 estimate on $2.5B revenue (est. $2.4B); Q3 EPS guidance of $1.97 against the $1.92 consensus.
−0.2% · S&P 500 +0.7%
EPS of $1.84 missed the $1.92 estimate on $2.4B revenue (est. $2.4B); FY EPS guidance of $6.00–$6.20 against the $6.31 consensus.
−2.1% · S&P 500 −1.8%
Where it ended: a close of $66.51 on Nov 11, 2026. Up next: Q4 2026 earnings on Jan 28, 2027 (EPS est. $1.20, revenue est. $2.2B).
As of the Nov 11, 2026 close
Replay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for EMN and SPY from Benzinga historical bars. Not investment advice.